SCHEMBL20153296

SCHEMBL20153296

Cc1cc2c(nc1C)NCCC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UHRF1 Q96T88 1/20 0.51
NNMT P40261 1/20 0.41
ATM Q13315 1/20 0.35
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
HTR1D P28221 2/20 0.33
HTR1B P28222 2/20 0.33
ITGB3 P05106 5/20 0.32
ITGAV P06756 5/20 0.32
ITGB5 P18084 3/20 0.32
ITGB6 P18564 3/20 0.32
ITGB8 P26012 3/20 0.32
NUDT1 P36639 1/20 0.32
CXCR4 P61073 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16195787 0.82 UHRF1 (0.45) UHRF1NNMTATMPDE3BPDE3A
SCHEMBL21281649 0.80 UHRF1 (0.46) UHRF1NNMTATMHTR1DHTR1B
SCHEMBL22808764 0.80 UHRF1 (0.46) UHRF1NNMTATMHTR1DHTR1B
SCHEMBL21281647 0.80 UHRF1 (0.42) UHRF1NNMTPDE3BPDE3AITGB3
SCHEMBL12895015 0.80 UHRF1 (0.42) UHRF1NNMTATMPDE3BPDE3A
SCHEMBL23912895 0.78 UHRF1 (0.41) UHRF1NNMTPDE3BPDE3AITGB3
SCHEMBL30355149 0.77 NNMT (0.41) UHRF1NNMTPDE3BPDE3ANUDT1
SCHEMBL19402371 0.77 UHRF1 (0.44) UHRF1NNMTATMITGB3ITGAV
SCHEMBL5856503 0.73 UHRF1 (0.37) UHRF1NNMTITGB3ITGAVITGB5
SCHEMBL31364209 0.73 UHRF1 (0.40) UHRF1NNMTPDE3BPDE3AITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538525-B1 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2022-06-22 EP disclosed
EP-3538527-B1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-10-13 EP disclosed
EP-3538519-B1 INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2021-07-28 EP disclosed
EP-3538528-B1 PYRROLE AMIDES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-12-23 EP disclosed
WO-2018089357-A1 INDAZOLE DERIVATIVES AS αV INTEGRIN ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed
WO-2018089353-A1 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed
WO-2018089355-A1 CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed
WO-2018089360-A1 PYRROLE AMIDES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed